Literature DB >> 22150724

Increased serum concentrations of adhesion molecules but not of chemokines in patients with Type 2 diabetes compared with patients with Type 1 diabetes and latent autoimmune diabetes in adult age: action LADA 5.

M N Pham1, M I Hawa, M Roden, G Schernthaner, P Pozzilli, R Buzzetti, W A Scherbaum, J Seissler, S Hunter, R D G Leslie, H Kolb, N C Schloot.   

Abstract

AIMS: Systemic concentrations of adhesion molecules and chemokines are associated with increased risk of cardiovascular complications. We compared these factors between patients with Type 2 diabetes vs. Type 1 diabetes or latent autoimmune diabetes in adults.
METHODS: Serum concentrations of adhesion molecules sE-selectin, sICAM-1 and sVCAM-1, and chemokines CCL2, CCL3 and CCL4 were measured in 61 patients with latent autoimmune diabetes in adults, 90 with Type 1 diabetes, 465 with Type 2 diabetes and in 41 control subjects, using multiple regression models to adjust for possible confounders.
RESULTS: Patients with Type 2 diabetes exhibited greater concentrations of adhesion molecules (P < 0.02) than those with Type 1 diabetes, latent autoimmune diabetes in adults and control subjects. These differences persisted upon adjustments for age, sex, BMI, blood pressure and diabetes duration (P < 0.04). Higher BMI positively correlated with concentrations of adhesion molecules in all subjects (P < 0.0001). Concentrations of sE-selectin positively related to diastolic (β = 0.31) and systolic (β = 0.28) blood pressure in the adjusted model (P < 0.04). Concentrations of the chemokines, CCL2 and CCL4, did not differ between groups, while CCL3 was higher in patients with latent autoimmune diabetes in adults and Type 1 diabetes than in those with Type 2 diabetes and control subjects (P < 0.05).
CONCLUSIONS: Systemic concentrations of adhesion molecules, but not chemokines, relate to cardiovascular risk factors, but remain higher after adjustments in Type 2 diabetes, suggesting a diabetes-type specific effect without difference between latent autoimmune diabetes in adults and Type 1 diabetes, despite their dissimilar phenotype.
© 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22150724     DOI: 10.1111/j.1464-5491.2011.03546.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  16 in total

1.  Fatty acids modulate cytokine and chemokine secretion of stimulated human whole blood cultures in diabetes.

Authors:  M C Simon; S Bilan; B Nowotny; T Dickhaus; V Burkart; N C Schloot
Journal:  Clin Exp Immunol       Date:  2013-06       Impact factor: 4.330

Review 2.  Innate immunity in latent autoimmune diabetes in adults.

Authors:  Juan Huang; James Alexander Pearson; F Susan Wong; Li Wen; Zhiguang Zhou
Journal:  Diabetes Metab Res Rev       Date:  2021-06-22       Impact factor: 4.876

3.  A Novel Resolution of Diabetes: C-C Chemokine Motif Ligand 4 Is a Common Target in Different Types of Diabetes by Protecting Pancreatic Islet Cell and Modulating Inflammation.

Authors:  Ting-Ting Chang; Liang-Yu Lin; Jaw-Wen Chen
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

4.  Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis.

Authors:  Xiongfeng Pan; Atipatsa C Kaminga; Shi Wu Wen; Aizhong Liu
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

Review 5.  Latent autoimmune diabetes of the adult: current knowledge and uncertainty.

Authors:  E Laugesen; J A Østergaard; R D G Leslie
Journal:  Diabet Med       Date:  2015-02-07       Impact factor: 4.359

Review 6.  Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes?

Authors:  Ting-Ting Chang; Jaw-Wen Chen
Journal:  Cardiovasc Diabetol       Date:  2016-08-24       Impact factor: 9.951

7.  Altered intragenic DNA methylation of HOOK2 gene in adipose tissue from individuals with obesity and type 2 diabetes.

Authors:  Sandra Rodríguez-Rodero; Edelmiro Menéndez-Torre; Gustavo Fernández-Bayón; Paula Morales-Sánchez; Lourdes Sanz; Estrella Turienzo; Juan José González; Ceferino Martinez-Faedo; Lorena Suarez-Gutiérrez; Jessica Ares; Lucia Díaz-Naya; Alicia Martin-Nieto; Juan L Fernández-Morera; Mario F Fraga; Elías Delgado-Álvarez
Journal:  PLoS One       Date:  2017-12-11       Impact factor: 3.240

8.  HbA1c is Positively Associated with Serum Carcinoembryonic Antigen (CEA) in Patients with Diabetes: A Cross-Sectional Study.

Authors:  Jun Lu; Hongtao Wang; Xueli Zhang; Xuemei Yu
Journal:  Diabetes Ther       Date:  2018-01-04       Impact factor: 2.945

9.  High-mobility group box-1 induces decreased brain-derived neurotrophic factor-mediated neuroprotection in the diabetic retina.

Authors:  Ahmed M Abu El-Asrar; Mohd Imtiaz Nawaz; Mohammad Mairaj Siddiquei; Abdullah S Al-Kharashi; Dustan Kangave; Ghulam Mohammad
Journal:  Mediators Inflamm       Date:  2013-05-20       Impact factor: 4.711

10.  Effect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patients.

Authors:  Tarek Mk Motawi; Mohamed A Abou-Seif; Ahmed Ma Bader; Mohamed O Mahmoud
Journal:  BMC Endocr Disord       Date:  2013-08-21       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.